VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $942,307 | +74.8% | 35,017 | +95.6% | 0.01% | +40.0% |
| Q2 2023 | $538,969 | -6.9% | 17,900 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $579,065 | +9.8% | 17,900 | -2.7% | 0.01% | 0.0% |
| Q4 2022 | $527,344 | +18.8% | 18,400 | 0.0% | 0.01% | +20.0% |
| Q3 2022 | $444,000 | -11.9% | 18,400 | 0.0% | 0.01% | -16.7% |
| Q2 2022 | $504,000 | -39.8% | 18,400 | -15.7% | 0.01% | -33.3% |
| Q1 2022 | $837,000 | +55.3% | 21,830 | +29.7% | 0.01% | +80.0% |
| Q4 2021 | $539,000 | +8.7% | 16,830 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $496,000 | -13.3% | 16,830 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $572,000 | -0.7% | 16,830 | -5.0% | 0.01% | -14.3% |
| Q1 2021 | $576,000 | -9.7% | 17,720 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $638,000 | -7.0% | 17,720 | +1.1% | 0.01% | -25.0% |
| Q3 2020 | $686,000 | +25.9% | 17,530 | +18.0% | 0.01% | +9.1% |
| Q2 2020 | $545,000 | +64.7% | 14,860 | +3.5% | 0.01% | +10.0% |
| Q1 2020 | $331,000 | -47.0% | 14,360 | -32.8% | 0.01% | -37.5% |
| Q4 2019 | $625,000 | +9.5% | 21,360 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $571,000 | +5.0% | 21,360 | +0.4% | 0.02% | -5.9% |
| Q2 2019 | $544,000 | +14.8% | 21,280 | +0.7% | 0.02% | +6.2% |
| Q1 2019 | $474,000 | +6.3% | 21,130 | 0.0% | 0.02% | -5.9% |
| Q4 2018 | $446,000 | +14.1% | 21,130 | 0.0% | 0.02% | +30.8% |
| Q3 2018 | $391,000 | -17.0% | 21,130 | 0.0% | 0.01% | -27.8% |
| Q2 2018 | $471,000 | -25.8% | 21,130 | -26.9% | 0.02% | -30.8% |
| Q1 2018 | $635,000 | +39.9% | 28,911 | +48.0% | 0.03% | +44.4% |
| Q4 2017 | $454,000 | -53.1% | 19,531 | -53.6% | 0.02% | -57.1% |
| Q3 2017 | $967,000 | +120.8% | 42,131 | +112.5% | 0.04% | +110.0% |
| Q2 2017 | $438,000 | -4.6% | 19,831 | -1.5% | 0.02% | -4.8% |
| Q1 2017 | $459,000 | +6.2% | 20,139 | -2.5% | 0.02% | -4.5% |
| Q4 2016 | $432,000 | -16.9% | 20,664 | +5.1% | 0.02% | -18.5% |
| Q3 2016 | $520,000 | -47.8% | 19,664 | -45.3% | 0.03% | -50.9% |
| Q2 2016 | $996,000 | – | 35,943 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |